Lugano, Switzerland

Roberto Herklotz

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kantonsspital Aarau Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roberto Herklotz. Retrieved from https://idiyas.com/inventor/roberto-herklotz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Roberto Herklotz

Introduction

Roberto Herklotz is a notable inventor based in Lugano, Switzerland. He has made significant contributions to the field of genetic analysis, particularly through his innovative patent related to gene dosage analysis. His work has implications for understanding genetic polymorphisms and their detection.

Latest Patents

Roberto holds a patent for a method of detecting the presence of a genetic polymorphism within two or more closely linked, homologous genes, such as α-thalassemia. This invention utilizes RT-PCR techniques, involving separate amplification reactions with specific primers for both the head and tail regions of the genes in question. The method allows for the detection and quantification of amplification products relative to a control product. He has 1 patent to his name.

Career Highlights

Roberto is currently associated with Kantonsspital Aarau AG, where he applies his expertise in genetic research and analysis. His work at this institution has allowed him to contribute to advancements in medical genetics and diagnostics.

Collaborations

Roberto has collaborated with esteemed colleagues such as Andreas R. Huber and Luca Bernasconi. These partnerships have fostered a collaborative environment that enhances research and innovation in their field.

Conclusion

Roberto Herklotz's contributions to genetic analysis through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the understanding of genetic disorders and their detection.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…